Please note that to receive credit you must achieve a score of at least 70%.

Physicians: Certificate of Credit will be emailed within 4 weeks of successful completion of the activity.

Pharmacists: The information that you participated will be uploaded to CPE Monitor within 4 weeks of successful completion of the activity and you will be able to access your credits from the profile you set up with NABP. For more information, please visit http://www.nabp.net/.

Question Title

1. Which of the following multidrug-resistant (MDR) organisms results in the greatest number of deaths annually in the US?

Question Title

2. The percent of S. aureus isolates in hospitals that exhibit methicillin resistance is approximately:

Question Title

3. Rapid diagnostic tests to identify MRSA infections include all of the following except:

Question Title

4. FDA-approved antimicrobials for the treatment of MRSA pneumonia include all of the following except:

Question Title

5. Carbapenem-resistance by P. aeruginosa occurs rarely (<3% of isolates) in the US?

Question Title

6. Which of the following antimicrobials approved by the FDA in 2014 exhibits effective antipseudomonal activity?

Question Title

7. Clinical study evidence has shown the recurrence rate of C. difficile infection (CDI) following vancomycin treatment is approximately:

Question Title

8. First-line therapy for an initial episode of severe CDI is:

Question Title

9. An effective treatment option for patients with multiple CDI episodes is:

Question Title

10. Compared to vancomycin, the use of fidaxomicin in the treatment of CDI resulted in significantly:

( Privacy & Cookie Notice

T